CA2097087A1 - Combinaison de composes vanilloides et de composes antiviraux nucleosidiques pour le traitement d'infections herpetiques - Google Patents

Combinaison de composes vanilloides et de composes antiviraux nucleosidiques pour le traitement d'infections herpetiques

Info

Publication number
CA2097087A1
CA2097087A1 CA002097087A CA2097087A CA2097087A1 CA 2097087 A1 CA2097087 A1 CA 2097087A1 CA 002097087 A CA002097087 A CA 002097087A CA 2097087 A CA2097087 A CA 2097087A CA 2097087 A1 CA2097087 A1 CA 2097087A1
Authority
CA
Canada
Prior art keywords
issued
hydroxy
compound
methyl
vanilloid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002097087A
Other languages
English (en)
Inventor
Lawrence Raymond Stanberry
Larry Milton Brand
Benjamin Franklin Floyd
Timothy Peter O'neill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2097087A1 publication Critical patent/CA2097087A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
CA002097087A 1990-11-27 1991-11-25 Combinaison de composes vanilloides et de composes antiviraux nucleosidiques pour le traitement d'infections herpetiques Abandoned CA2097087A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61875790A 1990-11-27 1990-11-27
US618,757 1990-11-27

Publications (1)

Publication Number Publication Date
CA2097087A1 true CA2097087A1 (fr) 1992-05-28

Family

ID=24479012

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002097087A Abandoned CA2097087A1 (fr) 1990-11-27 1991-11-25 Combinaison de composes vanilloides et de composes antiviraux nucleosidiques pour le traitement d'infections herpetiques

Country Status (7)

Country Link
EP (1) EP0559744A1 (fr)
JP (1) JPH06502865A (fr)
AU (1) AU9073691A (fr)
CA (1) CA2097087A1 (fr)
IE (1) IE914112A1 (fr)
MX (1) MX9102245A (fr)
WO (1) WO1992009287A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0347000B1 (fr) * 1988-06-17 1994-10-26 The Procter & Gamble Company Utilisation de dérivés de la vanilline pour la fabrication d'un médicament utile dans le traitement de l'infection de l'herpes simplex

Also Published As

Publication number Publication date
AU9073691A (en) 1992-06-25
EP0559744A1 (fr) 1993-09-15
JPH06502865A (ja) 1994-03-31
IE914112A1 (en) 1992-06-03
WO1992009287A1 (fr) 1992-06-11
MX9102245A (es) 1992-07-08

Similar Documents

Publication Publication Date Title
CA2998189C (fr) Procedes pour le traitement d'infections virales a arenaviridae et coronaviridae
AU2014224111B2 (en) Positively charged water-soluble prodrugs of 1H-imidazo[4,5-c]quinolin-4-amines and related compounds with very high skin penetration rates
US8895531B2 (en) 2′-fluoronucleoside phosphonates as antiviral agents
SA95160244B1 (ar) نوكليوسيدات علاجية therapeutic nucleosides
PL160322B1 (pl) Sposób wytwarzania 5-podstawionych nukleozydów pirymidynowych PL PL PL
JPH06507902A (ja) 肝臓で代謝される薬物前駆物の決定とその治療的利用
JPH08510236A (ja) 局所使用のためのアシクロビル誘導体
US20050261251A1 (en) Antiviral agents and methods of treating viral infections
US20090274686A1 (en) Nucleoside phosphonate derivatives
JPH06508846A (ja) アシル化ピリミジンヌクレオシドによる化学療法剤および抗ウイルス剤毒性の治療
Descamps et al. Relative potencies of different anti-herpes agents in the topical treatment of cutaneous herpes simplex virus infection of athymic nude mice
EP0479336A1 (fr) Composés antiviraux
JP2002538200A (ja) 長鎖炭化水素およびヌクレオシド類似体によるウイルス複製の相乗的阻害
JP2724711B2 (ja) 医薬品生成物
JPS59186985A (ja) ジメチルアミノメチレン化された抗ヘルペス化合物
WO1992009285A1 (fr) Combinaisons de composes vanilloides et de composes phosphonates antiviraux pour le traitement d'infections par herpes
CA2097087A1 (fr) Combinaison de composes vanilloides et de composes antiviraux nucleosidiques pour le traitement d'infections herpetiques
CA2207503C (fr) Emploi d'agents antiviraux a base d'aminopurine pour le traitement et la prophylaxie d'infections latentes par les herpesvirus
JP2000507211A (ja) 単純ヘルペス感染症の組合せ治療におけるヌクレオシド類似体
Maudgal et al. Evaluation of bromovinyldeoxyuridine-related compounds in the treatment of experimental herpes simplex keratitis
EP0113998A2 (fr) Compositions et traitement d'infections virales à Herpes Simplex
CA1302887C (fr) Melange d'acyclovir (ou d'un de ses devises) et de bacitracine
KR960015953B1 (ko) 피부에 축적하는 외용의 항바이러스성 약학적 조성물 및 그 제조방법
US7618950B2 (en) Method for treatment and prevention of herpes zoster by topical application
EP0082667A1 (fr) Compositions pharmaceutiques

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead